Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Additional side effect alert for individuals on weight-loss injections this week - Featured image
Health

Additional side effect alert for individuals on weight-loss injections this week

Shotlee Editorial Team
Written by Shotlee Editorial TeamHealth Research & Writing
·January 9, 2026·3 min read

On this page

  • Restarting Weight-Loss Medication Safely
  • Insights from a Pharmacy Expert
  • Guidelines for Resuming Treatment
  • Reporting Side Effects

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

Thousands are resuming their weight-loss drugs after holiday pauses, but experts caution about heightened side effects. Research indicates many users wait until New Year to restart regimens. Follow guidelines to avoid rebound issues and manage doses safely.

Share

On this page

  • Restarting Weight-Loss Medication Safely
  • Insights from a Pharmacy Expert
  • Guidelines for Resuming Treatment
  • Reporting Side Effects

Restarting Weight-Loss Medication Safely

Following a reduction in doses during the holiday season for some indulgent eating, numerous individuals are now resuming their weight management treatments. Healthcare professionals caution about more pronounced adverse reactions. This follows findings from CheqUp research, which revealed that almost two-thirds of GLP-1 users who lowered their intake intended to resume their standard schedule only after January 1st.

Stopping therapy abruptly can impact hunger, digestion, and blood sugar regulation, especially with increased carb and sweetener consumption. Experts note that inconsistent usage might heighten the chance of recurring issues and unwanted effects.

Insights from a Pharmacy Expert

Aaron Arman, Chief Pharmacist at CheqUp, commented: "We generally recommend avoiding sudden halts in GLP-1 therapy unless medically necessary, as it could result in elevated blood glucose levels and quick weight recapture. Individuals might not realize how much such interruptions disrupt sustained goals."

"These drugs function by managing appetite, metabolism, and sugar levels, so discontinuing them abruptly eliminates those safeguards, complicating the return to healthy habits. Those who temporarily halt their meds could face more intense side effects upon resumption, requiring adaptation time."

Guidelines for Resuming Treatment

Aaron offers recommendations for those picking up their weight-loss drugs in the New Year:

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play
  • Avoid Doubling Doses: Never take an extra amount if you skip one. These medications accumulate gradually, so overdoing it won't accelerate results but raises side effect risks. Inspect your injection device before reuse.
  • Storage Checks: Ensure proper refrigeration (typically 2-8°C) before restarting. Verify the solution is transparent and particle-free. Discard if cloudy, tinted, or particulate, and get a replacement.

Specific Instructions for Wegovy (semaglutide)

If one or two doses have been missed and fewer than five days have elapsed since the last planned shot, proceed with the injection as soon as recalled and revert to your weekly routine. If over five days, omit the skipped one and await the next scheduled date.

Specific Instructions for Mounjaro (tirzepatide)

For missing one or two doses within four days of the due time, administer promptly and resume the normal weekly pattern. If exceeding four days, skip and hold for the following regular day. Consult a doctor if several weeks have passed.

If three or more doses (about three weeks) are omitted, reach out to your healthcare provider prior to restarting. They might suggest a reduced starting dose or modified plan to minimize adverse reactions.

Reporting Side Effects

Report any adverse responses upon restart, particularly if they seem worse than initial experiences. Contact your prescriber for secure management strategies. Health tracking apps like Shotlee can assist in monitoring progress and symptoms effectively.

Source Information

Originally published by Devon Live.Read the original article →

Read next

Keep exploring

More on Wegovy

Articles covering Wegovy dosing, side effects, and clinical updates.

What's the Deal with Peptides? The Hyped Market Under FDA Review
Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read
Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program
Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read
Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials
Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

Same topic: weight loss drugs

All weight loss drugs articles →
I Lost 5 Stone on Mounjaro — But Now I’ve Had Enough
Health & Wellness

I Lost 5 Stone on Mounjaro — But Now I’ve Had Enough

Natalie Lavergne transformed her health and lost 5 stone using Mounjaro, but now plans to switch to the Wegovy pill. Discover the medical realities of stopping weight loss medication.

8 min read
The Most Confronting Side Effect of Wegovy Weight Loss Wasn't Physical
Weight Management

The Most Confronting Side Effect of Wegovy Weight Loss Wasn't Physical

While physical side effects of Wegovy are well-documented, one patient's experience highlights a profound, non-physical challenge: the shift in how society perceives and treats individuals after significant weight loss.

7 min read
Novo Nordisk Sues Eli Lilly Over Which GLP-1 Sheds the Most Pounds
Medical News

Novo Nordisk Sues Eli Lilly Over Which GLP-1 Sheds the Most Pounds

Novo Nordisk has filed a federal lawsuit against Eli Lilly, alleging deceptive advertising regarding the comparative weight loss efficacy of Zepbound and Wegovy. The dispute centers on dosage comparisons and clinical trial data interpretation.

8 min read

More in Health

Wegovy Pill in New Jersey Stores: Where to Obtain It
Health

Wegovy Pill in New Jersey Stores: Where to Obtain It

The new Wegovy GLP-1 pill for weight loss is now accessible in New Jersey stores. With growing interest in these medications, this guide covers availability, pricing, and key safety information. Health tracking apps like Shotlee can assist in monitoring progress during use.

2 min read
Christmas Dinner Warning for Ozempic Users: 'Food Was Bubbling Up'
Health

Christmas Dinner Warning for Ozempic Users: 'Food Was Bubbling Up'

Allison Rankin recounts her experience of discomfort and vomiting after overeating at a family Christmas dinner while taking Mounjaro. Doctors caution against overeating on weight loss drugs due to slowed digestion.

4 min read
GLP-1 Agonists Associated with Persistent Cough
Health

GLP-1 Agonists Associated with Persistent Cough

A recent study has uncovered a potential connection between glucagon-like peptide-1 (GLP-1) receptor agonists and chronic cough in individuals managing type 2 diabetes. The research suggests that those using GLP-1 drugs were more prone to developing a persistent cough compared to those on alternative second-line treatments.

1 min read
Share this article
  1. Home
  2. Blog
  3. Additional side effect alert for individuals on weight-loss injections this week
Shotlee Editorial Team — Health Research & Writing
Written by

Shotlee Editorial Team

Health Research & Writing

Shotlee’s guides and articles are researched and written in-house by the Shotlee Editorial Team. We build every page from primary sources — FDA labels, official prescribing information, and peer-reviewed clinical trials — and cite them directly. Our content is educational and is not a substitute for advice from your own healthcare provider.

View all articles by Shotlee Editorial Team
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community